Hospital Inpatient Drug Spending Up 23%, Driven By Price Increases
Older drugs and high-volume drugs contributed substantially to the increases, study conducted on behalf of hospital trade groups finds.
You may also be interested in...
Which is stupider: Smirking, pleading the Fifth and then calling a Congressional Committee “imbeciles” on Twitter? Or spending four hours apologizing for excessive price increases and then running two DTC commercials during the Super Bowl?
Former senior advisor to President Trump warns that failure to reform drug pricing practices has seriously handicapped prospects for reimbursing cell and gene therapy under existing US payer programs.
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’